Chih-Ming Ho Ph.D

dr.ho.jpg

Distinguished Research Professor
Department of Mechanical & Aerospace Engineering
Department of Bioengineering

44-116C Engineering IV
 | Ho Lab Personalized Medicine

Education

  • B.S., National Taiwan University, 1967
  • Ph.D., Johns Hopkins University, 1974

Awards and Recognitions

  • Member: US National Academy of Engineering
  • Academician: Academia Sinica
  • Doctor of Engineering Honoris Causa: Hong Kong University of Science and Technology
  • Fellow: The American Association for the Advancement of Science (AAAS)
  • Fellow: American Institute of Medical and Biological Engineering (AIMBE)
  • Fellow: American Physical Society (APS)
  • Fellow: American Institute of Aeronautics and Astronautics (AIAA)
  • Fellow: International Society for Nano Manipulation, Manufacturing and Measurement (3M-Nano)
  • Ben Rich – Lockheed Martin Professor
  • Einstein Professor, Chinese Academy of Sciences
  • K. T. Lee Honorary Chair Professor of National Cheng Kung University
  • Honorary Research Professor of National Taiwan University
  • Kuo-Nien Honorary Professor of National Tsinghua University
  • Honorary Chair Professor of National Chao-Tung University
  • Honorary Chair Professor of National Tsinghua University
  • Honorary Professor of Institute of Mechanics, Chinese Academy of Sciences
  • Honorary Professor of Nanjing University of Aeronautics and Astronautics

Research Interests

After receiving his Ph.D. from Johns Hopkins University, Dr. Chih-Ming Ho started his career at the University of Southern California and rose to the rank of full professor. In 1991, he moved to the University of California, Los Angeles (UCLA) to lead the university’s establishment of the micro-electro-mechanical-system (MEMS) field, while serving as the founding Director of the Center for Micro Systems. He held the Ben Rich-Lockheed Martin Professor Chair until he retired in 2016, and currently is a UCLA Distinguished Research Professor. Dr. Ho was the Director of the NASA supported Institute for Cell Mimetic Space Exploration (CMISE) and the NIH supported Center for Cell Control (CCC). He served as UCLA Associate Vice Chancellor for Research from 2001 to 2005.

His research interests include phenotypic personalized medicine (PPM), micro/nano fluidics, molecular sensors and turbulence. He was ranked by ISI as one of the top 250 most cited researchers in all engineering categories (2001-2014). In 1997, Dr. Ho was inducted as a member of the National Academy of Engineering. In the next year, he was elected as an Academician of Academia Sinica. He has received a Doctor of Engineering Honoris Causa from Hong Kong University of Science and Technology and Dr. Ho holds ten honorary professorships, including the Einstein Professor from the Chinese Academy of Sciences. Dr. Ho was elected a Fellow of APS, AAAS, AIMBE, AIAA and 3M-Nano Society.

In addition to his academic accomplishments, he has made extensive contributions to many professional societies around the world. He has chaired the Division of Fluid Dynamics (DFD) for the American Physical Society, which is the leading platform in the United States for scientists interested in fundamental fluid dynamics. He was on the advisory board for the AIAA Journal and is a member of the IEEE/ASME JMEMS coordinating Committee. He was an Associate Editor of the ASME Journal of Fluids Engineering and an Associate Editor of the AIAA Journal. He also has served as a Guest Editor for the Annual Review of Fluid Dynamics.

On the international level, he has served on advisory panels to provide assistance to many countries and regions, including China, France, Hong Kong, Israel, Japan, Korea, Switzerland, Taiwan, Thailand, and the United Kingdom on the developments of nano/micro technologies. Dr. Ho also has chaired or served on numerous organizing committees of international conferences on high technology topics.

Recent Publications

1. Lee, B.Y., Clemens, D.L., Silva, A., Dillon, B.J., Sasˇa Maslesˇa-Galic´, Nava, S., Ding, X., Ho, C.M., and Horwitz, M.A., “Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time”, Nat. Commun. 8, 14183 doi: 10.1038/ncomms14183, 2017.

2. Chen, Y.T., Goudar, V.S., Wu, R.G., Hsieh, H.Y., Yang, C.S., Chang H.Y., Lee, G.B., Ho, C.M., and Tseng, F.G.., “A UV-sensitive hydrogel based combinatory drug delivery chip (UV gel-Drug Chip) for cancer cocktail drug screening”, RSC Adv. | 6:44425 | DOI: 10.1039/C6RA01733A, 2016.

3. Nowak-Sliwinska, P., Weiss, A., Ding, X., Dyson, P.J., van den Bergh, H., Griffioen, A.W., and Ho, C.M., “Optimization of drug combinations using Feedback System Control”, Nature Protocols, Vol. 11, No. 2, pp. 302-315, 2016.

4. Silva, A., Lee, B.Y., Clemens, D.L., Kee, T., Ding, X., Ho, C.M. and Horwitz, M.A., “Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using A macrophage cell culture model”, PNAS, Vol. 113, No. 15, 2016.

5. Zarrinpar, A., Lee, D.-K., Silva, A., Datta, N., Kee, T., Eriksen, C., Weigle, K., Agopian, V., Kaldas, F., Farmer, D., Wang, S.E., Busuttil, R., Ho, C.M., “Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform”, Sci. Transl. Med. 8, 333ra49, 2016.

6. Jaynes, J., Zhao, Y., Xu, H., and Ho, C.M., “Use of Orthogonal Array Composite Designs to Study Lipid Accumulation in a Cell-Free System”, Qual. Reliab. Engng. Int., 32, 1965–1974, 2016.

7. Fei, P., Lee, J., Packard, R.R.S., Sereti, K.I., Xu, H., Ma, J., Ding, Y., Kang, H., Chen, H., Sung, K., Kulkarni, R., Ardehali, R., Kuo, C.C., Xu, X., Ho, C.M., and Hsiai, T.K., “Cardiac Light-Sheet Fluorescent Microscopy for Multi-Scale and Rapid Imaging of Architecture and Function”, Scientific Reports | 6:22489 | DOI: 10.1038/srep22489, 2016.